Table of Contents Author Guidelines Submit a Manuscript
Canadian Respiratory Journal
Volume 15, Suppl B, Pages 1B-19B
http://dx.doi.org/10.1155/2008/973062
Asthma Worsenings Working Group

Asthma Worsenings: Approaches to Prevention and Management from the Asthma Worsenings Working Group

Meyer Balter,1 Pierre Ernst,2 Wade Watson,3 Harold Kim,4 Lisa Cicutto,5 Marie-France Beauchesne,6 Andrew J Cave,7 Alan Kaplan,8 Donna Hogg,9 Andrew McIvor,10 Tom Smiley,11 Michel Rouleau,12 and J Mark FitzGerald13

1University of Toronto, Mount Sinai Hospital, Toronto, Ontario, Canada
2McGill University, Montréal, Québec, Canada
3Department of Pediatrics, Dalhousie University, Division of Allergy, IWK Health Centre, Halifax, Nova Scotia, Canada
4McMaster University, University of Western Ontario, Allergy and Clinical Immunology, Kitchener, Ontario, Canada
5Universities of Toronto and Colorado, National Jewish Medical Research Center, Denver, Colorado, USA
6Faculty of Pharmacy, University of Montréal, Hôpital du Sacré-Coeur de Montréal, Montréal, Québec, Canada
7Department of Family Medicine, University of Alberta, University of Alberta Hospital, Edmonton, Alberta, Canada
8Family Physician Airways Group of Canada, York Central Hospital, Richmond Hill, Ontario, Canada
9College and Association of Registered Nurses of Alberta, Edmonton, Alberta, Canada
10McMaster University, St Joseph’s Healthcare, Firestone Institute for Respiratory Health, Hamilton, Ontario, Canada
11Pharmavision Health Consulting Inc, Paris, Ontario, Canada
12Laval University, Québec, Canada
13Respiratory Division, University of British Columbia, Vancouver General Hospital, Vancouver, British Columbia, Canada

Copyright © 2008 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Citations to this Article [43 citations]

The following is the list of published articles that have cited the current article.

  • Rebecca Mann, and Jake Nichols, “Management of Chronic Obstructive Pulmonary Disease,” American Journal of Lifestyle Medicine, vol. 3, no. 6, pp. 458–465, 2009. View at Publisher · View at Google Scholar
  • Antonio Anzueto, and Antonio Anzueto, “Primary Care Management of Chronic Obstructive Pulmonary Disease to Reduce Exacerbations and Their Consequences,” American Journal Of The Medical Sciences, vol. 340, no. 4, pp. 309–318, 2010. View at Publisher · View at Google Scholar
  • Adrienne S. Scott, Marcel A. Baltzan, Esther Dajczman, and Norman Wolkove, “Patient Knowledge in Chronic Obstructive Pulmonary Disease: Back to Basics,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 8, no. 5, pp. 375–379, 2011. View at Publisher · View at Google Scholar
  • Stuart W. Stoloff, and Stuart W. Stoloff, “Chronic Obstructive Pulmonary Disease Megatrials: Taking the Results into Office Practice,” American Journal Of The Medical Sciences, vol. 342, no. 2, pp. 160–167, 2011. View at Publisher · View at Google Scholar
  • Catherine Simpson, “Advance care planning in COPD,” Chronic Respiratory Disease, vol. 9, no. 3, pp. 193–204, 2012. View at Publisher · View at Google Scholar
  • S. Gupta, F. T. Wan, F. M. Ducharme, M. H. Chignell, M. D. Lougheed, S. E. Straus, S. Gupta, F. T. Wan, F. M. Ducharme, M. H. Chignell, M. D. Lougheed, and S. E. Straus, “Asthma action plans are highly variable and do not conform to best visual design practices,” Annals Of Allergy Asthma & Immunology, vol. 108, no. 4, pp. 260–U111, 2012. View at Publisher · View at Google Scholar
  • Andrea S. Gershon, Thomas E. Dolmage, Anne Stephenson, and Beth Jackson, “Chronic Obstructive Pulmonary Disease and SocioEconomic Status: a Systematic Review,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 9, no. 3, pp. 216–226, 2012. View at Publisher · View at Google Scholar
  • Yannick Molgat-Seon, Jeremy D. Road, and A. William Sheel, “Do isolated leg exercises improve dyspnea during exercise in chronic obstructive pulmonary disease?,” Applied Physiology, Nutrition, and Metabolism, vol. 38, no. 9, pp. 996–998, 2013. View at Publisher · View at Google Scholar
  • Anthony D’Urzo, “Optimizing the management of chronic obstructive pulmonary disease: applying the GOLD strategy,” Clinical Practice, vol. 10, no. 4, pp. 481–492, 2013. View at Publisher · View at Google Scholar
  • Smita Pakhale, Vanessa Luks, Andrew Burkett, and Lucy Turner, “Effect of physical training on airway inflammation in bronchial asthma: a systematic review,” BMC Pulmonary Medicine, vol. 13, no. 1, 2013. View at Publisher · View at Google Scholar
  • John Bukowski, Mark Nicolich, and R. Jeffrey Lewis, “Extreme Sensitivity and the Practical Implications of Risk Assessment Thresholds,” Dose-Response, vol. 11, no. 2, pp. dose-response.1, 2013. View at Publisher · View at Google Scholar
  • Yoshitake Yamada, Masahiro Jinzaki, Masahiro Hashimoto, Eisuke Shiomi, Takayuki Abe, Sachio Kuribayashi, and Kenji Ogawa, “Tomosynthesis for the early detection of pulmonary emphysema: diagnostic performance compared with chest radiography, using multidetector computed tomography as reference,” European Radiology, vol. 23, no. 8, pp. 2118–2126, 2013. View at Publisher · View at Google Scholar
  • N. Barnes, P.M.A. Calverley, A. Kaplan, and K.F. Rabe, “Chronic obstructive pulmonary disease and exacerbations: clinician insights from the global Hidden Depths of COPD survey,” Current Medical Research and Opinion, vol. 30, no. 4, pp. 667–684, 2013. View at Publisher · View at Google Scholar
  • G. M. Rocker, A. C. Simpson, R. Horton, T. Sinuff, J. Demmons, P. Hernandez, and D. Marciniuk, “Opioid therapy for refractory dyspnea in patients with advanced chronic obstructive pulmonary disease: patients' experiences and outcomes,” CMAJ Open, vol. 1, no. 1, pp. E27–E36, 2013. View at Publisher · View at Google Scholar
  • E.W. Russi, W. Karrer, M. Brutsche, C. Eich, J.W. Fitting, M. Frey, T. Geiser, M. Kuhn, L. Nicod, F. Quadri, T. Rochat, C. Steurer-Stey, and D. Stolz, “Diagnosis and Management of Chronic Obstructive Pulmonary Disease: The Swiss Guidelines,” Respiration, vol. 85, no. 2, pp. 160–174, 2013. View at Publisher · View at Google Scholar
  • Katherine Krauskopf, Alex D. Federman, Minal S. Kale, Keith M. Sigel, Melissa Martynenko, Rachel O’Conor, Michael S. Wolf, Howard Leventhal, and Juan P. Wisnivesky, “Chronic Obstructive Pulmonary Disease Illness and Medication Beliefs are Associated with Medication Adherence,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 12, no. 2, pp. 151–164, 2014. View at Publisher · View at Google Scholar
  • Anthony D D'Urzo, M Reza Maleki-Yazdi, and R Andrew McIvor, “Evolving therapies in chronic obstructive pulmonary disease,” Clinical Practice, vol. 11, no. 3, pp. 307–325, 2014. View at Publisher · View at Google Scholar
  • Eric D Bateman, Donald A Mahler, Claus F Vogelmeier, Jadwiga A Wedzicha, Francesco Patalano, and Donald Banerji, “Recent advances in COPD disease management with fixed-dose long-acting combination therapies,” Expert Review of Respiratory Medicine, vol. 8, no. 3, pp. 357–379, 2014. View at Publisher · View at Google Scholar
  • A. Ismaila, D. Corriveau, J. Vaillancourt, D. Parsons, A. Dalal, Z. Su, and J.S. Sampalis, “Impact of adherence to treatment with tiotropium and fluticasone propionate/salmeterol in chronic obstructive pulmonary diseases patients,” Current Medical Research and Opinion, vol. 30, no. 7, pp. 1427–1436, 2014. View at Publisher · View at Google Scholar
  • Bahareh HajGhanbari, Cristiane Yamabayashi, Road Jayne Garland, Jeremy D. Road, and Darlene W. Reid, “The Relationship Between Pain and Comorbid Health Conditions in People with Chronic Obstructive Pulmonary Disease,” Cardiopulmonary Physical Therapy Journal, vol. 25, no. 1, pp. 29–35, 2014. View at Publisher · View at Google Scholar
  • Wan C. Tan, Jean Bourbeau, Denis O'Donnell, Shawn Aaron, Francois Maltais, Darcy Marciniuk, Paul Hernandez, Robert Cowie, Kenneth Chapman, A. Sonia Buist, Don Sin, and J. Mark Fitzgerald, “Quality Assurance of Spirometry in a Population-Based Study –Predictors of Good Outcome in Spirometry Testing,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 11, no. 2, pp. 143–151, 2014. View at Publisher · View at Google Scholar
  • Timothy E Albertson, and Andrew L Chan, “Antibiotic therapy in elderly patients with acute exacerbation of chronic bronchitis,” Expert Review of Respiratory Medicine, vol. 3, no. 5, pp. 539–548, 2014. View at Publisher · View at Google Scholar
  • Zab Mosenifar, “Differentiating COPD from Asthma in Clinical Practice,” Postgraduate Medicine, vol. 121, no. 3, pp. 105–112, 2015. View at Publisher · View at Google Scholar
  • Richard Casaburi, and Karen Duvall, “Improving Early-Stage Diagnosis and Management of COPD in Primary Care,” Postgraduate Medicine, vol. 126, no. 4, pp. 141–154, 2015. View at Publisher · View at Google Scholar
  • Nicole Marquis, Pierre Larivee, Didier Saey, Marie-France Dubois, Michel Tousignant, Nicole Marquis, Pierre Larivee, Didier Saey, Marie-France Dubois, and Michel Tousignant, “In-Home Pulmonary Telerehabilitation for Patients with Chronic Obstructive Pulmonary Disease: A Pre-experimental Study on Effectiveness, Satisfaction,,” Telemedicine And E-Health, vol. 21, no. 11, pp. 870–879, 2015. View at Publisher · View at Google Scholar
  • Laura E. Labonté, Wan C. Tan, Pei Z. Li, Palmina Mancino, Shawn D. Aaron, Andrea Benedetti, Kenneth R. Chapman, Robert Cowie, J. Mark FitzGerald, Paul Hernandez, François Maltais, Darcy D. Marciniuk, Dennis O'Donnell, Don Sin, and Jean Bourbeau, “Undiagnosed Chronic Obstructive Pulmonary Disease Contributes to the Burden of Health Care Use. Data from the CanCOLD Study,” American Journal of Respiratory and Critical Care Medicine, vol. 194, no. 3, pp. 285–298, 2016. View at Publisher · View at Google Scholar
  • Christopher Plishka, Thomas Rotter, Leigh Kinsman, Mohammed Rashaad Hansia, Adegboyega Lawal, Donna Goodridge, Erika Penz, and Darcy D. Marciniuk, “Effects of clinical pathways for chronic obstructive pulmonary disease (COPD) on patient, professional and systems outcomes: protocol for a systematic review,” Systematic Reviews, vol. 5, no. 1, 2016. View at Publisher · View at Google Scholar
  • Bahareh Ghadaki, Nadine Kronfli, Thuva Vanniyasingam, and Shariq Haider, “Chronic obstructive pulmonary disease and HIV: are we appropriately screening?,” AIDS Care, vol. 28, no. 10, pp. 1338–1343, 2016. View at Publisher · View at Google Scholar
  • Denis E. O’Donnell, Katherine A. Webb, Ingrid Harle, and J. Alberto Neder, “Pharmacological management of breathlessness in COPD: recent advances and hopes for the future,” Expert Review of Respiratory Medicine, pp. 1–12, 2016. View at Publisher · View at Google Scholar
  • Melvin Morganroth, Ginger Pape, Yelena Rozenfeld, and John E. Heffner, “Multidisciplinary COPD disease management program: impact on clinical outcomes,” Postgraduate Medicine, vol. 128, no. 2, pp. 239–249, 2016. View at Publisher · View at Google Scholar
  • Andrea S. Gershon, Alice M. Newman, Hadas D. Fischer, Peter C. Austin, Nick Daneman, Chaim M. Bell, Anne L. Stephenson, Sudeep S. Gill, Nicholas T. Vozoris, and Paula A. Rochon, “Inhaled Long-acting Anticholinergics and Urinary Tract Infection in Individuals with COPD,” COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 14, no. 1, pp. 105–112, 2016. View at Publisher · View at Google Scholar
  • Linda Lee, Tejal Patel, Loretta M. Hillier, and James Milligan, “Office-Based Case Finding for Chronic Obstructive Pulmonary Disease in Older Adults in Primary Care,” Canadian Respiratory Journal, vol. 2016, pp. 1–7, 2016. View at Publisher · View at Google Scholar
  • Louis-Philippe Boulet, “The Expert Patient and Chronic Respiratory Diseases,” Canadian Respiratory Journal, vol. 2016, pp. 1–6, 2016. View at Publisher · View at Google Scholar
  • Andreas Eich, Veronika Urban, Marek Jutel, Jiri Vlcek, Jae Jeong Shim, Vasiliy I. Trofimov, Chong-Kin Liam, Ping-Hung Kuo, Yanyan Hou, Jun Xiao, Patrick Branigan, and Christopher D. O'Brien, “A Randomized, Placebo-Controlled Phase 2 Trial of CNTO 6785 in Chronic Obstructive Pulmonary Disease,” COPD: Journal of Chronic Obstructive Pulmonary Disease, pp. 1–8, 2017. View at Publisher · View at Google Scholar
  • Amany F. Elbehairy, Grace Parraga, Katherine A. Webb, J Alberto Neder, and Denis E. O’Donnell, “Mild chronic obstructive pulmonary disease: why spirometry is not sufficient!,” Expert Review of Respiratory Medicine, pp. 1–15, 2017. View at Publisher · View at Google Scholar
  • Marc Miravitlles, Antonio Anzueto, and Jos? R. Jardim, “Optimizing bronchodilation in the prevention of COPD exacerbations,” Respiratory Research, vol. 18, no. 1, 2017. View at Publisher · View at Google Scholar
  • F. S. Magnet, J. H. Storre, and W. Windisch, “Home oxygen therapy: evidence versus reality,” Expert Review of Respiratory Medicine, pp. 1–17, 2017. View at Publisher · View at Google Scholar
  • Paola Rogliani, Vito Brusasco, Leonardo Fabbri, Andrea Ungar, Elisa Muscianisi, Ilaria Barisone, Alberto Corsini, and Giuseppe De Angelis, “Multidimensional approach for the proper management of a complex chronic patient with chronic obstructive pulmonary disease,” Expert Review of Respiratory Medicine, pp. 1–10, 2017. View at Publisher · View at Google Scholar
  • Thomas Rotter, Christopher Plishka, Mohammed Rashaad Hansia, Donna Goodridge, Erika Penz, Leigh Kinsman, Adegboyega Lawal, Sheryl O’Quinn, Nancy Buchan, Patricia Comfort, Prakesh Patel, Sheila Anderson, Tanya Winkel, Rae Lynn Lang, and Darcy D. Marciniuk, “The development, implementation and evaluation of clinical pathways for chronic obstructive pulmonary disease (COPD) in Saskatchewan: protocol for an interrupted times series evaluation,” BMC Health Services Research, vol. 17, no. 1, 2017. View at Publisher · View at Google Scholar
  • Peter M. A. Calverley, Achim Mueller, Andrew Fowler, Norbert Metzdorf, and Robert A. Wise, “ The Effect of Defining Chronic Obstructive Pulmonary Disease by the Lower Limit of Normal of FEV 1 /FVC Ratio in Tiotropium Safety and Performance in Respimat Participants ,” Annals of the American Thoracic Society, vol. 15, no. 2, pp. 200–208, 2018. View at Publisher · View at Google Scholar
  • Jiangtao Lin, Xin Zhou, Changzheng Wang, Chuntao Liu, Shaoxi Cai, and Mao Huang, “Symbicort® Maintenance and Reliever Therapy (SMART) and the evolution of asthma management within the GINA guidelines,” Expert Review of Respiratory Medicine, pp. 1–12, 2018. View at Publisher · View at Google Scholar
  • Iraj Poureslami, Jessica Shum, Richard T. Lester, Hamid Tavakoli, Delbert R. Dorscheid, and J. Mark FitzGerald, “A pilot randomized controlled trial on the impact of text messaging check-ins and a web-based asthma action plan versus a written action plan on asthma exacerbations,” Journal of Asthma, pp. 1–13, 2018. View at Publisher · View at Google Scholar
  • Andrea Aiello, Daniela Ritrovato, and Claudia Pitotti, “Budget impact model of indacaterol/glycopyrronium in the treatment of chronic obstructive pulmonary disease in Italy based on the FLAME study,” Global & Regional Health Technology Assessment: Italian; Northern Europe and Spanish, vol. 2018, pp. 228424031880480, 2018. View at Publisher · View at Google Scholar